logo-loader
viewOpen Orphan PLC

Open Orphan coronavirus testing machine arrives at hVivo's east London lab

The new kit has the capacity to perform 3,000 tests per day

Open Orphan PLC -

Open Orphan PLC (LON:ORPH) has confirmed that its coronavirus COVID-19 Antibody Microarray machine is on-site at hVivo's laboratory in east London and is undergoing testing.

The move follows the company’s recently announced tie-up with Quotient Limited. The machine, which will be fully operational in two weeks, can carry out 3,000 tests per day.

In Monday's update, Open Orphan also said it is in discussions with channel partners to secure new business.

“It is the intention to supply testing capability to channel partners, who will in turn deal with the end users and the final price points,” the company said.

Currently, home kits are retailing for £70-£150 each.

Quick facts: Open Orphan PLC

Price: 12.5 GBX

AIM:ORPH
Market: AIM
Market Cap: £82.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan PLC - Proactive One2One Virtual Event

Open Orphan PLC's (LON:ORPH) Cathal Friel speaks to investors at the Proactive One2One Virtual Event. Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical...

2 days, 12 hours ago

2 min read